Paces Ferry Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Paces Ferry Wealth Advisors, LLC
- $166 Million
- Q2 2024
A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 495 shares of REGN stock, worth $456,914. This represents 0.31% of its overall portfolio holdings.
Number of Shares
495
Previous 514
3.7%
Holding current value
$456,914
Previous $494,000
5.26%
% of portfolio
0.31%
Previous 0.32%
Shares
16 transactions
Others Institutions Holding REGN
# of Institutions
1,481Shares Held
85.5MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$7.64 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.47 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.28 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $98.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...